EUVIMEDEUVIMED entdecken
Open Access

Structure‐based design and biophysical characterization of the linker sequence that associate to the VH – VL domain interface of the single‐chain Fv antibody to suppress oligomerization propensity

Kyo Okazaki, Yoshihiro Kobashigawa iD, Hiroyuki Kumeta, Kose Aramaki, Takako Nagata, Sena Kamesawa, Takashi Sato, Hiroshi Morioka iD

Protein Science · 2026

DOI: 10.1002/pro.70450 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Protein Science, 2026. Verfasst von Kyo Okazaki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Analytical and Biophysical Chemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan. Hauptthemen laut MEDLINE: Single-Chain Antibodies, Immunoglobulin Light Chains, Immunoglobulin Heavy Chains, Immunoglobulin Variable Region. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) under KAKENHI, Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science (JSPS) through a JSPS Research Fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A single‐chain antibody is an artificial small size antibody fragment whose variable regions are connected by a flexible short peptide linker. The scFv antibody is considered an attractive molecule for constructing advanced therapeutic antibodies, such as CAR‐T cells and multi‐specific antibodies. However, the application of scFv antibodies in advanced drugs is limited by their propensity to oligomerize. Due to weak interactions between the VH and VL domains, scFvs exist in an equilibrium between open and closed states, leading to inter‐chain VH–VL interactions that form dimers, trimers, and aggregates. In this study, we designed a novel peptide linker that interacts with the VH–VL domain interface to shift this equilibrium toward the closed state. By comparing the structures of various antibodies, we identified a conserved groove in the interface region between the VH and VL domains, whose structure and sequence were conserved among antibodies. Utilizing various computational structural biological techniques, we designed a peptide fragment that binds to this groove effectively assembles the VH and VL domains together. The designed linker was introduced into scFv proteins with human and mouse frameworks and produced using a bacterial expression system. Size‐exclusion chromatography demonstrated that the novel linker suppressed dimer formation. Analysis after 7 days of storage in aqueous solution revealed that the designed linker also suppressed oligomer formation. Surface plasmon resonance experiments revealed that antigen‐binding affinity was not compromised by the designed linker. The new linker will facilitate the application study of scFv antibodies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Single-Chain AntibodiesImmunoglobulin Light ChainsImmunoglobulin Heavy ChainsImmunoglobulin Variable RegionHumansAnimalsMiceProtein MultimerizationAmino Acid SequenceModels, Molecular

Stichwörter der Autor:innen

Trastuzumabde novo designin silico designmolecular dynamicsscFv antibody

Substanzen

Single-Chain AntibodiesImmunoglobulin Light ChainsImmunoglobulin Heavy ChainsImmunoglobulin Variable Region

Autor:innen und Institutionen

  • Department of Analytical and Biophysical Chemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.
  • Frontier Research Center for Advanced Material and Life Science, Faculty of Advanced Life Science, Hokkaido University, Sapporo, Hokkaido, Japan.

ORCID-Profile: Yoshihiro Kobashigawa, Hiroshi Morioka

Förderung

  • Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) under KAKENHI
  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science (JSPS) through a JSPS Research Fellowship

Zitieren

APA

Okazaki, K., Kobashigawa, Y., Kumeta, H., Aramaki, K., Nagata, T., Kamesawa, S., Sato, T., & Morioka, H. (2026). Structure‐based design and biophysical characterization of the linker sequence that associate to the VH – VL domain interface of the single‐chain Fv antibody to suppress oligomerization propensity. Protein Science. https://doi.org/10.1002/pro.70450

Vancouver

Okazaki K, Kobashigawa Y, Kumeta H, Aramaki K, Nagata T, Kamesawa S, et al. Structure‐based design and biophysical characterization of the linker sequence that associate to the VH – VL domain interface of the single‐chain Fv antibody to suppress oligomerization propensity. Protein Science. 2026. doi:10.1002/pro.70450

BibTeX
@article{Okazaki2026,
  author = {Okazaki, Kyo and Kobashigawa, Yoshihiro and Kumeta, Hiroyuki and Aramaki, Kose and Nagata, Takako and Kamesawa, Sena and Sato, Takashi and Morioka, Hiroshi},
  title = {Structure‐based design and biophysical characterization of the linker sequence that associate to the VH – VL domain interface of the single‐chain Fv antibody to suppress oligomerization propensity},
  journal = {Protein Science},
  year = {2026},
  doi = {10.1002/pro.70450}
}
Kostenlos starten →